DTC-0315

N/A

Report date: 2024/09/26 18:01:06
NME

Base Information

Drug NameDTC-0315
Drug Alias NameDTC-0315
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase JAK3 inhibitorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK3Tyrosine-protein kinase 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDELiver Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDELiver Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A